MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
119 hedge funds and large institutions have $78.7M invested in Merrimack Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
68% less capital invested
Capital invested by funds: $246M → $78.7M (-$167M)
Holders
119
Holding in Top 10
–
Calls
$242K
Puts
$473K
Top Buyers
| 1 | +$537K | |
| 2 | +$385K | |
| 3 | +$331K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$184K |
| 5 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
+$179K |
Top Sellers
| 1 | -$5.42M | |
| 2 | -$4.29M | |
| 3 | -$2.57M | |
| 4 |
LIM
Lagoda Investment Management
New York
|
-$2.39M |
| 5 |
AWCI
Alpine Woods Capital Investors
Purchase,
New York
|
-$2.24M |